The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Itochu Offers $1.56 Billion to Privatize Dentsu Soken 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Toyota Global Sales Fall as China Demand Slumps 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Meta, U.S. States Discuss Settlement in Teen Addiction Trial 
Honda, Nissan Eye Shared Vehicle Software Platform by 2029 
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’ 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Street Poller Media and The Boom of the Street Interview Ad Industry 
Amazon Secures 200 MW Wind Power Deals in Sweden 
Add as a preferred source on Google
WARSAW, Ind., April 09, 2018 -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced it will continue its Diamond sponsorship for the 37th Annual European Paediatric Orthopaedic Society (EPOS) meeting, which will take place April 11 – 14 in Oslo, Norway. OrthoPediatrics has been a leading sponsor of the Society since the Company’s inception.
At the meeting, OrthoPediatrics will also sponsor a lunch symposium titled “Management of Open Fractures in Children”, featuring a panel of key opinion leaders from around the world. The panelists will discuss the most frequent types of fractures, guidelines for antibiotic use, evidence-based surgical treatment and the management of soft tissue injuries in open fractures in children. The panel will be moderated by Dr. Pierre Journeau, with additional discussion and case presentations by Drs. Annelie Weinberg, Manoj Ramachandran, and Manon Bachy.
OrthoPediatrics’ President & CEO Mark Throdahl, commented, “We are pleased to continue our leading support of EPOS, one of the world’s largest pediatric orthopedic scientific organizations. This society has remained steadfastly dedicated to elevating the quality of care for children with orthopedic conditions. OrthoPediatrics has shared this mission since our inception, and so we are proud to continue supporting the clinical education of pediatric surgeons as we work together to improve the lives of children with orthopedic conditions around the world.”
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 24 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This offering spans trauma & deformity, scoliosis and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 37 countries outside the United States.
Investor Contacts
The Ruth Group
Tram Bui / Emma Poalillo
(646) 536-7035 / 7024
[email protected] / [email protected]
